Back to Search
Start Over
Nanomedicines accessible in the market for clinical interventions.
Nanomedicines accessible in the market for clinical interventions.
- Source :
-
Journal of Controlled Release . Feb2021, Vol. 330, p372-397. 26p. - Publication Year :
- 2021
-
Abstract
- Nanomedicines refers to nanotechnology inspired pharmaceutical products often referred to as 'nanopharmaceuticals.' It has displayed commendable potential in enhancing therapeutic efficacy as well as in reducing the side effects associated with conventional drug counterpart. Recent years have monitored the entry of a large amount of nanomedicine in the market with an appreciable market share to date. Despite this, the development of nanomedicine is posing challenges (i.e., safety, regulatory hurdles, cost, scale-up issues, etc.) that need to be resolved for their market entry. This review presents a cross-sectional discussion on the nanomedicine-derived products available in the market for both clinical and diagnostic applications. An overview of its market potential, market size, and the products that are currently in the clinical stages is also provided. The review also expounds on the challenges faced by nano-drug products at the time of their commercialization. Unlabelled Image • Nanomedicines have displayed commendable potential in enhancing therapeutic efficacy and reducing side effects. • Nanomedicine-derived products have entered the market with an appreciable market share • Current global nanomedicine market (US$ 293.1 billion) is growing at a CAGR of 14.0%. • Safety, cost, scale-up, and regulatory concerns must be addressed for clinical translation. • Review presents a cross-sectional discussion on nanomedicine-products for clinical and diagnostic applications. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01683659
- Volume :
- 330
- Database :
- Academic Search Index
- Journal :
- Journal of Controlled Release
- Publication Type :
- Academic Journal
- Accession number :
- 148861702
- Full Text :
- https://doi.org/10.1016/j.jconrel.2020.12.034